Tedisamil (KC 8857) is a new specific bradycardic drug: Does it also influence myocardial contractility? Analysis by the conductance (volume) technique in coronary artery disease-Reference-Cited by-同舟云学术

Tedisamil (KC 8857) is a new specific bradycardic drug: Does it also influence myocardial contractility? Analysis by the conductance (volume) technique in coronary artery disease

Published:1993-05 Issue:5 Volume:125 Page:1233-1246
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Thormann Jochen,Mitrovic Veselin,Riedel Herbert,Neuzner Jörg,Strasser Rudolf,Bahavar Hassan,Schlepper Martin

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference57 articles.

1. Effects of heart rate on coronary flow and cardiac oxygen consumption;Laurent;Am J Physiol,1956

2. The metabolic demand and oxygen supply of the heart. Physiologic and clinical considerations;Weber;Am J Cardiol,1979

3. Specific bradycardic agents, a new approach to therapy in angina pectoris;Kobinger;Prog Pharmacol,1985

4. Tedisamil: cardiac electrophysiologic and functional effects in guinea pigs;Fuchs;Naunyn Schmiedebergs Arch Pharmacol,1989

5. Further studies into the ECG effects of tedisamil (KC 8857) in rats [Abstract];Howard,1989

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tedisamil attenuates foetal transformation of myosin in the hypertrophied rat myocardium;British Journal of Pharmacology;2004-11

2. Tedisamil: a new novel antiarrhythmic;Expert Opinion on Investigational Drugs;2004-02

3. New Antiarrhythmic Drugs;Cardiac Electrophysiology;2004

4. New Antiarrhythmic Drugs for the Treatment of Atrial Fibrillation;Pacing and Clinical Electrophysiology;2002-02

5. Conversion of Atrial Fibrillation by the Experimental Antiarrhythmic Drug Tedisamil in Two Canine Models;Journal of Cardiovascular Electrophysiology;2001-10